Partner Pipeline
partner |
program |
animal source |
area |
phase 1 |
phase 2 |
phase 3 |
registration |
approved |
---|---|---|---|---|---|---|---|---|
Gloria Pharmaceuticals Arcus Biosciences |
Zimberelimab | OmniRat | Oncology | |||||
CStone Pharmaceuticals | Sugemalimab | OmniRat | Oncology | |||||
Janssen | Teclistamab | OmniRat | Oncology | |||||
Genentech | Tiragolumab | OmniRat | Oncology | |||||
Hanall Biopharma Immunovant Harbour BioMed |
Batoclimab | OmniRat | Immunology | |||||
Genmab | GEN1046 | OmniRat | Oncology | |||||
Undisclosed | Undisclosed | OmniRat | Undisclosed | |||||
Genmab | GEN1047 | OmniRat | Oncology | |||||
Aptevo Therapeutics | APVO436 | OmniMouse | Oncology | |||||
Janssen | JNJ-67371244 | OmniMouse | Oncology | |||||
Janssen | JNJ-70218902 | OmniRat | Oncology | |||||
Janssen | JNJ-8306358 | OmniRat | Oncology | |||||
Merck | M6223 | OmniRat | Oncology | |||||
Symphogen | SYM022 | OmniRat | Oncology | |||||
Symphogen | SYM023 | OmniRat | Oncology | |||||
Symphogen | SYM024 | OmniRat | Oncology | |||||
Symphogen | S095029 | OmniRat | Oncology | |||||
AbbVie | TNB-383B | OmniFlic | Oncology | |||||
Ancora | TNB-486 | OmniFlic | Oncology | |||||
Amgen | AMG 340 | OmniFlic | Oncology | |||||
SalubrisBio | SAL003 | OmniRat | Metabolic | |||||
Boehringer Ingelheim | Undisclosed | OmniChicken | Undisclosed | |||||
Curon | CN1 | OmniRat | Oncology | |||||
Zhilkang Hongyi | Undisclosed | OmniRat | Undisclosed | |||||
Undisclosed | Undisclosed | OmniRat | Undisclosed |
Partner | Gloria Pharmaceuticals Arcus Biosciences |
---|---|
Program | Zimberelimab |
Animal Source | OmniRat |
Area | Oncology |
Phase | Approved |
Partner | CStone Pharmaceuticals |
Program | Sugemalimab |
Animal Source | OmniRat |
Area | Oncology |
Phase | Approved |
Partner | Janssen |
Program | Teclistamab |
Animal Source | OmniRat |
Area | Oncology |
Phase | Registration |
Partner | Genentech |
Program | Tiragolumab |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 3 |
Partner | Hanall Biopharma Immunovant Harbour BioMed |
Program | Batoclimab |
Animal Source | OmniRat |
Area | Immunology |
Phase | Phase 3 |
Partner | Genmab |
Program | GEN1046 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 2 |
Partner | Undisclosed |
Program | Undisclosed |
Animal Source | OmniRat |
Area | Undisclosed |
Phase | Phase 2 |
Partner | Genmab |
Program | GEN1047 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | Aptevo Therapeutics |
Program | APVO436 |
Animal Source | OmniMouse |
Area | Oncology |
Phase | Phase 1 |
Partner | Janssen |
Program | JNJ-67371244 |
Animal Source | OmniMouse |
Area | Oncology |
Phase | Phase 1 |
Partner | Janssen |
Program | JNJ-70218902 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | Janssen |
Program | JNJ-8306358 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | Merck |
Program | M6223 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | Symphogen |
Program | SYM022 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | Symphogen |
Program | SYM023 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | Symphogen |
Program | SYM024 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | Symphogen |
Program | S095029 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | AbbVie |
Program | TNB-383B |
Animal Source | OmniFlic |
Area | Oncology |
Phase | Phase 1 |
Partner | Ancora |
Program | TNB-486 |
Animal Source | OmniFlic |
Area | Oncology |
Phase | Phase 1 |
Partner | Amgen |
Program | AMG 340 |
Animal Source | OmniFlic |
Area | Oncology |
Phase | Phase 1 |
Partner | SalubrisBio |
Program | SAL003 |
Animal Source | OmniRat |
Area | Metabolic |
Phase | Phase 1 |
Partner | Boehringer Ingelheim |
Program | Undisclosed |
Animal Source | OmniChicken |
Area | Undisclosed |
Phase | Phase 1 |
Partner | Curon |
Program | CN1 |
Animal Source | OmniRat |
Area | Oncology |
Phase | Phase 1 |
Partner | Zhilkang Hongyi |
Program | Undisclosed |
Animal Source | OmniRat |
Area | Undisclosed |
Phase | Phase 1 |
Partner | Undisclosed |
Program | Undisclosed |
Animal Source | OmniRat |
Area | Undisclosed |
Phase | Phase 1 |